{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-079342","form_type":"8-K","ticker":"ALXO","cik":"0001810182","company_name":"ALX ONCOLOGY HOLDINGS INC","filed_at":"2026-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.261405+00:00","generated_at":"2026-05-15T23:09:13.762020+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ALX Oncology Q4 GAAP net loss $22.8M ($0.42/sh), completes $150M offering, cash runway to 1H 2028","bullets":["Cash $48.3M at Dec 31, 2025; after Feb 2026 $150M offering net $140.4M, runway through 1H 2028.","GAAP net loss Q4 2025 ($22.8M)/($0.42) vs ($29.2M)/($0.55) in Q4 2024; full year ($101.7M)/($1.90) vs ($134.9M)/($2.58).","R&D expenses Q4 2025 $17.6M vs $23.5M in Q4 2024; full year $77.0M vs $116.4M.","Barbara Klencke appointed permanent CMO; completed $150M registered equity offering in Feb 2026.","Clinical milestones: evorpacept biomarker data; ASPEN-09 enrollment expanded to 120 pts, topline mid-2027; ALX2004 safety data 2H 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-079342","json":"https://secwatch.observer/filing/0001193125-26-079342.json","markdown":"https://secwatch.observer/filing/0001193125-26-079342.md","text":"https://secwatch.observer/filing/0001193125-26-079342.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526079342/0001193125-26-079342-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810182/000119312526079342/alxo-20260227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:09:13.762020+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}